RecruitingPHASE1, PHASE2NCT06417411

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto Nacional de Investigacao em Saude, Angola
Principal Investigator
JOANA MORAIS, PhD
INSTITUTO NACIONAL DE INVESTIGAÇÃO EM SAÚDE
Intervention
Aspirin 100mg(drug)
Enrollment
450 target
Eligibility
15 years · FEMALE
Timeline
2024 – 2026

Study locations (1)

Collaborators

FUNDACIÓN BANCARIA CAIXA D'ESTALVIS I PENSIONS DE BARCELONA · Calouste Gulbenkian Foundation · CLINCOORD SERVICES, INC. · CLINCOORD PRESTAÇÃO DE SEVIÇOS, LDA ANGOLA · Escola Superior de Tecnologia da Saúde de Lisboa · ClinCoord Research Center at Luanda Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06417411 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials